Vodis Pharmaceuticals announces $1.6M private placement

Photo of author

By CPE News

Vancouver (pcJ News Briefs) – Vodis Pharmaceuticals Inc. (CSE: VP; FSE: 1JV1) intends to close a non-brokered private placement of 4,000,000 units at a price of $0.40 for gross proceeds of $1,600,000 on April 18, 2017.

Each unit will comprise one common share and one transferable full share purchase warrant exercisable at a price of $0.50 for two years from the date of issuance. In connection with this financing, the Vodis Pharmaceuticals will not be paying any finders’ fees.

Proceeds will be used to complete the final expansion of the company’s facility in Bellingham, Washington.

Vodis Pharmaceuticals Inc. is a medical and recreational marijuana business with operations in both the United States and Canada. The company, with facilities in BC and Washington State, is also actively looking into expansion opportunities in other countries and states in the United States.

photo credit: Vodis Pharmaceuticals